Pharmacogenomics

Papers
(The TQCC of Pharmacogenomics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations34
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN1225
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization24
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing23
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level22
Rapid point of care testing: the next frontier in pharmacogenomics21
Pharmacogenetics of Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Patients: the SUCLINGEN Study21
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report19
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications18
A Meta-Analysis of Effects of Cyp2C9 and Cyp2C19 Polymorphisms on Phenytoin Pharmacokinetic Parameters18
KRAS-Targeted Therapies in Advanced Solid Cancers: Drug the Undruggable?17
Integrated in a Systems Pharmacology Approach, Pharmacogenetics holds the Promise for Personalized Medicine in Neonates15
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison15
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations14
CYP2D6 Gene Resequencing in the Malagasy, a Population at the Crossroads between Asia and Africa: A Pilot Study13
Multiple Genetic Mutations Increase the Risk of Thrombosis Associated With Clopidogrel After Percutaneous Coronary Intervention12
Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective study11
Gene Polymorphisms Affect Postoperative Imatinib Plasma Levels and Edema in Adults With Gastrointestinal Stromal Tumor11
Association of NAT-2 Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy11
Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam10
Methods for Actionable Gene Fusion Detection in Lung Cancer: Now and in the Future10
The cost–effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma10
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration10
The Promise�of Digital Health in Healthcare Equity and Medication Adherence in the Disadvantaged Dementia Population10
EFfects of UGT1A , CYP2C9/19 and ABAT Polymorphisms on Plasma Concentration of Valproic Acid in Chinese Epi10
A Survey of Physician Opinions in Russia in the Field of Pharmacogenetics of Cardiovascular Disease10
Improving the Management of ALK-Rearranged Non-Small-Cell Lung Cancer Through a Mobile Application: A Physicians-Based Survey9
UGT1A1 Genotype-Guided Dosing of Irinotecan: Time to Prioritize Patient Safety9
Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeutics9
Head-to-head Comparison of Various Antipsychotic Agents on Genome-Wide Methylation in Schizophrenia8
A critical review of RAF inhibitors in BRAF-mutated glioma treatment8
Genetic Factors Associated with Tuberculosis-Related Clinical Outcomes in HIV-Infected Black African Patients: a Systematic Review and Meta-Analysis8
SLCO1B1 and ABCB1 Variants Synergistically Influence the Atorvastatin Treatment Response in South Indian Coronary Artery Disease Patients8
Impact of genetic variants on fentanyl metabolism in major breast surgery patients: a candidate gene association study8
Effects of CYP3A4 and CYP2C9 Genotype on Systemic Anastrozole and Fulvestrant Concentrations in SWOG S02268
TPMT and NUDT15 genotyping, TPMT enzyme activity and metabolite determination for thiopurines therapy: a reference laboratory experience8
Genetika+: Precision Medicine Solutions for Mental Health8
The Festival of Genetics and Personalized Medicine7
DDX11-AS1 Modulates Dna Damage Repair to Enhance Paclitaxel Resistance of Lung Adenocarcinoma Cells7
Erratum7
Carbamazepine Cutaneous Adverse Reactions and HLA Gene Variation in the Chinese Population: A Systematic Review and Meta-Analysis7
Association between CYP3A4 , CYP3A5 and ABCB1 Genotype and Tacrolimus Treatment Outcomes Among Allogeneic H7
Predicting laboratory aspirin resistance in Chinese stroke patients using machine learning models by GP1BA polymorphism7
Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data7
Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review7
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations7
Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patients7
Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability6
Polymorphisms in the CYP3A5 Gene Significantly Affect the Pharmacokinetics of Sirolimus After Kidney Transplantation6
Pharmacogenomics in Pediatric Medicine and Drug Development6
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case–control study6
Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation6
Patient Satisfaction With Return of Pharmacogenomic Results Utilizing a Patient Portal Message6
Glutathione S -transferase Gene Polymorphism and Asthma: A Case–Control Study in a Pediatric Population6
Polymorphisms of Genes Related to Phase II Metabolism and Resistance to Clopidogrel6
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants6
Impact of CYP2C19 Gene Polymorphisms on Warfarin Dose Requirement: A Systematic Review and Meta-Analysis5
Dosage Optimization of Clopidogrel Via a Precision Medicine Approach: The Way Forward5
Bioinformatic Tools are Essential to Integrating Pharmacogenomics into Clinical Practice: Lessons from Neuropsychiatric Disorders5
Genetic polymorphisms of OPRM1 on the Efficacy and Safety of Anesthetic and Analgesic Agents: A Systematic Review5
XDH Genotypes Through Gene–Gene Interactions with NUDT15 Affect Azathioprine-Induced Leukopenia in Chinese Patients5
Pharmacogenomic curriculum in Australian medical schools: a content analysis study5
Overview of the Year 2023 at Pharmacogenomics5
Pharmacogenomic Study of Anthracycline-Induced Cardiotoxicity in Mexican Pediatric Patients5
Pharmacogenomic Landscape of Covid-19 Therapies From Indian Population Genomes5
Pharmacogenomics: A Tool to Improve Medication Safety and Efficacy in Patients with Cystic Fibrosis5
Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases5
Influence of CYP3A5 , IL-10 Polymorphisms and Metabolism Rate on Tacrolimus Exposure in Renal Post-Transplant Recipients5
Tabula Rasa Healthcare Company Profile: Involvement in Pharmacogenomic and Personalized Medicine Research5
Relevance of NAT2 Genotype and Clinical Factors to Risk for Antituberculosis Drug-Induced Liver Injury5
The Effects of Sex on Pharmacogenetically Guided Drug Treatment5
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions5
DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?5
KCNQ1 Variant rs163184 is a Potential Biomarker of Glycemic Response to Exenatide4
Artificial intelligence, medications, pharmacogenomics, and ethics4
Engaging Pharmacogenomics in Pain Management and Opioid Selection4
Pharmacogenomic Prescribing Opportunities in Percutaneous Coronary Intervention and Bone Marrow Transplant Patients4
Genome-Wide Association Study of Liver Enzyme Elevation in an Extended Cohort of Rheumatoid Arthritis Patients Starting Low-Dose Methotrexate4
ATP Binding Cassette Transporters and Cancer: Revisiting Their Controversial Role4
Congruence Rates for Pharmacogenomic Noninterruptive Alerts4
Relevance of NR1I2 Variants on Carbamazepine Therapy in Mexican Mestizos with Epilepsy at a Tertiary-Care Hospital4
The Revolution of Pharmaco-Omics: Ready to Open new Avenues in Materializing Precision Medicine?4
Healthcare Professionals’ Knowledge, Confidence and Perceptions of Pharmacogenomics in Primary Care and Pain Management4
Single-Nucleotide Polymorphisms in ABC Drug Transporters Alter Expression and Circulating Tenofovir in Healthy South African Women Exposed to Pre-Exposure Prophylaxis4
Leveraging Clinical Decision Support to Reduce the Risk of Discordant Pharmacogenomics Results4
Pharmacogenetics of HIV Therapy: Challenges for Tailoring Treatment in Genetically Complex Populations4
Pharmacogenomics Implementation: “ A Little Less Conversation, a Little More Action, Please ”4
Association of CYP2C19 , CYP3A4 and ABCC2 Polymorphisms and Voriconazole Plasma Concentrations in Uygur Ped4
Clinical Pharmacology and Pharmacogenomics for Implementation of Personalized Medicine4
SLCO1B3 Polymorphisms and Clinical Outcomes in Kidney Transplant Recipients Receiving Mycophenolate4
Psychiatric Level 1A Evidence Pharmacogenomics in a Brazilian Admixed Cohort and Global Populations4
The Importance of Phenoconversion when using the CYP2D6 Genotype in Clinical Practice4
Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review4
The Frequency Of Rs2231142 in ABCG2 Among Native Hawaiian nd Pacific Islander Subgroups: Implications for Personalized Rosuvastatin Dosing4
Effect of UGT1A6 and UGT2B7 polymorphisms on the valproic acid serum concentration and drug-induced liver injury4
Evaluation of Pentamidine Tolerability and Efficacy Between CYP2C19 Phenotypes4
0.071758985519409